Clinical Trial Detail

NCT ID NCT04175431
Title Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: senior adult

No variant requirements are available.